StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 08 Nov 2021 07:35:25 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday EyeGate (EYEG) is Now Kiora Pharmaceuticals (KPRX); Provides Update on Company’s Sharpened Clinical Development Strategy http://www.streetinsider.com/Corporate+News/EyeGate+%28EYEG%29+is+Now+Kiora+Pharmaceuticals+%28KPRX%29%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174297.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/EyeGate+%28EYEG%29+is+Now+Kiora+Pharmaceuticals+%28KPRX%29%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174297.html for the full story. http://www.streetinsider.com/Corporate+News/EyeGate+%28EYEG%29+is+Now+Kiora+Pharmaceuticals+%28KPRX%29%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174297.html Mon, 08 Nov 2021 07:35:25 -0500 EYEG KPRX EyeGate (EYEG) is Now Kiora Pharmaceuticals (KPRX); Provides Update on Company’s Sharpened Clinical Development Strategy http://www.streetinsider.com/Corporate+News/EyeGate+%28EYEG%29+is+Now+Kiora+Pharmaceuticals+%28KPRX%29%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174297.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/EyeGate+%28EYEG%29+is+Now+Kiora+Pharmaceuticals+%28KPRX%29%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174297.html for the full story. http://www.streetinsider.com/Corporate+News/EyeGate+%28EYEG%29+is+Now+Kiora+Pharmaceuticals+%28KPRX%29%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174297.html Mon, 08 Nov 2021 07:35:25 -0500 EYEG KPRX Form 8-K KIORA PHARMACEUTICALS For: Nov 05 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KIORA+PHARMACEUTICALS+++++For%3A+Nov+05/19174288.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KIORA+PHARMACEUTICALS+++++For%3A+Nov+05/19174288.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KIORA+PHARMACEUTICALS+++++For%3A+Nov+05/19174288.html Mon, 08 Nov 2021 07:33:00 -0500 EYEG EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development Strategy http://www.streetinsider.com/Press+Releases/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Mon, 08 Nov 2021 07:30:00 -0500 EYEG KPRX EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development Strategy http://www.streetinsider.com/Press+Releases/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Mon, 08 Nov 2021 07:30:00 -0500 EYEG KPRX EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development Strategy http://www.streetinsider.com/Globe+Newswire/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html for the full story. http://www.streetinsider.com/Globe+Newswire/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Mon, 08 Nov 2021 07:30:00 -0500 EYEG KPRX EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development Strategy http://www.streetinsider.com/Globe+Newswire/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html for the full story. http://www.streetinsider.com/Globe+Newswire/EyeGate+is+Now+Kiora+Pharmaceuticals%3B+Provides+Update+on+Company%E2%80%99s+Sharpened+Clinical+Development+Strategy/19174232.html Mon, 08 Nov 2021 07:30:00 -0500 EYEG KPRX Form D EYEGATE PHARMACEUTICALS http://www.streetinsider.com/SEC+Filings/Form++D++++++++++EYEGATE+PHARMACEUTICALS++++++++++++++/19163737.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++D++++++++++EYEGATE+PHARMACEUTICALS++++++++++++++/19163737.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++D++++++++++EYEGATE+PHARMACEUTICALS++++++++++++++/19163737.html Thu, 04 Nov 2021 16:23:00 -0500 EYEG Form 4 EYEGATE PHARMACEUTICALS For: Nov 02 Filed by: FROM STEPHEN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+FROM+STEPHEN/19154549.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+FROM+STEPHEN/19154549.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+FROM+STEPHEN/19154549.html Wed, 03 Nov 2021 16:17:00 -0500 EYEG Form 4 EYEGATE PHARMACEUTICALS For: Nov 02 Filed by: Mann Brenda http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+Mann+Brenda/19154540.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+Mann+Brenda/19154540.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+Mann+Brenda/19154540.html Wed, 03 Nov 2021 16:17:00 -0500 EYEG Form 4 EYEGATE PHARMACEUTICALS For: Nov 02 Filed by: Romano Sarah http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+Romano+Sarah/19154533.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+Romano+Sarah/19154533.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Nov+02++Filed+by%3A+Romano+Sarah/19154533.html Wed, 03 Nov 2021 16:16:00 -0500 EYEG Form 8-K EYEGATE PHARMACEUTICALS For: Oct 21 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Oct+21/19103752.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Oct+21/19103752.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Oct+21/19103752.html Tue, 26 Oct 2021 07:01:00 -0500 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html for the full story. http://www.streetinsider.com/Globe+Newswire/EyeGate+Pharmaceuticals+Appoints+Eric+J.+Daniels%2C+MD%2C+MBA%2C+as+Chief+Development+Officer+and+Closes+Acquisition+of+Bayon+Therapeutics%2C+Inc./19103638.html Tue, 26 Oct 2021 07:00:00 -0500 A.03295816 A.09006848 A.24633582 A.30037484 EYEG Form 4 EYEGATE PHARMACEUTICALS For: Oct 04 Filed by: Romano Sarah http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Oct+04++Filed+by%3A+Romano+Sarah/19028294.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Oct+04++Filed+by%3A+Romano+Sarah/19028294.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EYEGATE+PHARMACEUTICALS+++For%3A+Oct+04++Filed+by%3A+Romano+Sarah/19028294.html Tue, 05 Oct 2021 18:41:00 -0500 EYEG